Galera Therapeutics, Inc. announced on August 9, 2023, Mark Bachleda, Pharm.D., the Company s Chief Commercial Officer, was informed that his position was being eliminated in connection with the. -Today at 08:01 am- MarketScreener
Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives. | May 11, 2023
Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products New Drug Application for. | May 1, 2023